rs2144492

Variant names:

• chr14-24308205-A-C
• rs2144492
• NM_174913.3:c.*3110A>C

Your query was ambiguous. Multiple possible variants found:

• chr14-24308205-A-C
• chr14-24308205-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_174913.3(NOP9):​c.*3110A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.946 in 311,668 control chromosomes in the GnomAD database, including 139,598 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: 𝑓 0.94 (66800 hom., cov: 32)
  • Exomes 𝑓: 0.96 (72798 hom.)
• Consequence: NOP9 NM_174913.3 3_prime_UTR
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.521
• Publications: 4 publications found

Genes affected

NOP9 (HGNC:19826): (NOP9 nucleolar protein) Enables RNA binding activity. Predicted to be involved in ribosome biogenesis. Predicted to be part of 90S preribosome and preribosome, small subunit precursor. Predicted to be active in nucleolus. [provided by Alliance of Genome Resources, Apr 2022]

CIDEB (HGNC:1977): (cell death inducing DFFA like effector b) Enables identical protein binding activity. Involved in activation of cysteine-type endopeptidase activity; positive regulation of cell death; and positive regulation of release of cytochrome c from mitochondria. Acts upstream of or within apoptotic process. Located in cytosol and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

LTB4R2 (HGNC:19260): (leukotriene B4 receptor 2) Predicted to enable G protein-coupled peptide receptor activity and leukotriene B4 receptor activity. Predicted to be involved in inflammatory response and neuropeptide signaling pathway. Predicted to act upstream of or within keratinocyte migration and signal transduction. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.82).
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.957 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174913.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NOP9	NM_174913.3	MANE Select	c.*3110A>C		3_prime_UTR	Exon 10 of 10	NP_777573.1
	NOP9	NM_001286367.2		c.*3247A>C		3_prime_UTR	Exon 10 of 10	NP_001273296.1
	CIDEB	NM_001318807.3		c.-63+274T>G		intron	N/A	NP_001305736.1

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NOP9	ENST00000267425.8	TSL:1 MANE Select	c.*3110A>C		3_prime_UTR	Exon 10 of 10	ENSP00000267425.3
	CIDEB	ENST00000258807.5	TSL:1	c.-63+274T>G		intron	N/A	ENSP00000258807.5
	CIDEB	ENST00000967605.1		c.-347T>G		5_prime_UTR	Exon 1 of 5	ENSP00000637664.1

Frequencies

GnomAD3 genomes AF: 0.936 AC: 142411 AN: 152146 Hom.: 66769 Cov.: 32

Gnomad AFR AF: 0.889

Gnomad AMI AF: 0.980

Gnomad AMR AF: 0.929

Gnomad ASJ AF: 0.963

Gnomad EAS AF: 0.849

Gnomad SAS AF: 0.948

Gnomad FIN AF: 0.975

Gnomad MID AF: 0.962

Gnomad NFE AF: 0.963

Gnomad OTH AF: 0.941

GnomAD4 exome AF: 0.955 AC: 152243 AN: 159404 Hom.: 72798 Cov.: 0 AF XY: 0.955 AC XY: 82381 AN XY: 86276

African (AFR) AF: 0.894 AC: 4517 AN: 5054

American (AMR) AF: 0.939 AC: 5150 AN: 5482

Ashkenazi Jewish (ASJ) AF: 0.960 AC: 4154 AN: 4326

East Asian (EAS) AF: 0.858 AC: 7155 AN: 8336

South Asian (SAS) AF: 0.957 AC: 24743 AN: 25862

European-Finnish (FIN) AF: 0.974 AC: 6221 AN: 6386

Middle Eastern (MID) AF: 0.972 AC: 616 AN: 634

European-Non Finnish (NFE) AF: 0.966 AC: 91823 AN: 95104

Other (OTH) AF: 0.957 AC: 7864 AN: 8220

GnomAD4 genome AF: 0.936 AC: 142497 AN: 152264 Hom.: 66800 Cov.: 32 AF XY: 0.935 AC XY: 69632 AN XY: 74454

African (AFR) AF: 0.889 AC: 36924 AN: 41524

American (AMR) AF: 0.928 AC: 14206 AN: 15300

Ashkenazi Jewish (ASJ) AF: 0.963 AC: 3342 AN: 3472

East Asian (EAS) AF: 0.849 AC: 4400 AN: 5184

South Asian (SAS) AF: 0.947 AC: 4566 AN: 4822

European-Finnish (FIN) AF: 0.975 AC: 10351 AN: 10616

Middle Eastern (MID) AF: 0.959 AC: 282 AN: 294

European-Non Finnish (NFE) AF: 0.963 AC: 65538 AN: 68024

Other (OTH) AF: 0.942 AC: 1994 AN: 2116

Alfa AF: 0.953 Hom.: 33587

Bravo AF: 0.930

Asia WGS AF: 0.901 AC: 3134 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.82
CADD	Benign	3.8
DANN	Benign	0.66
PhyloP100		-0.52
PromoterAI		-0.052	Neutral
Mutation Taster		=300/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs2144492; hg19: chr14-24777411;